Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2300105	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-06-03		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CYSB2101285	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-12-10		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CYSB2000377	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-23	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-03-16	view
JYSB2000668	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-22	view
JYSB2000667	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-12-28	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2021-03-22	view